Ethos Medical

Medical device developer based in Atlanta, working on ultrasound-guided needle placement technology.
Company overview
Ethos Medical develops technology intended to help clinicians guide needles using ultrasound imaging. Its principal product, Iris, is designed around the challenge of precise needle placement during medical procedures.
Publicly documented development activity includes university-linked usability research and non-dilutive research support. Public commercial adoption and customer counts have not been established in this prototype.
Leadership
2 peopleProducts & regulatory status How does MedTechIndex get this information?
Summary
Ethos states that its Iris needle-guidance system is not yet FDA cleared. No matching published marketing decision was found. Records for a 1990 Roto Rest hospital bed belong to a different Ethos business and are excluded. [13][11][1]
No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. [6][3]
Regulatory snapshot How to read this snapshot
U.S. FDA- 0
- 510(k) clearances
- 0
- De Novo grants
- 0
- PMA approvals
- 0
- Recall events
Latest recorded source review: 2026-10-20.
Scope: selected product families.
Commercial portfolio snapshot
No commercially marketed product portfolio has been established in the reviewed material.
Commercial development
Activity & Milestones
2 eventsUniversity-associated usability evaluation
Georgia Tech reported a medical-device usability study involving Ethos technology. This is evidence of evaluation activity, not proof of commercial adoption. [9]
NSF research funding
Georgia Tech reported NSF support for Ethos development efforts. Award details should be confirmed against official grant records. [8]
14 Cited Sources
Accessed 10/20/2026
14 Cited Sources
Accessed 10/20/2026
